Kaken Pharmaceutical , Ltd. Profit Margin

Kaken Pharmaceutical , Ltd.'s profit margin stands at 10.53% as of September 2026. That compares with 0.8% in the prior-year period — up 1210.5% year over year. That is below the sector sector average of 13.78%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Kaken Pharmaceutical , Ltd. reported 10.53% in profit margin versus 0.8% a year earlier — a 1210.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Kaken Pharmaceutical , Ltd. sits lower the its sector benchmark (13.78%) with a profit margin of 10.53%. That is roughly 23.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 10.53% for Kaken Pharmaceutical , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Kaken Pharmaceutical , Ltd.'s profit margin evolved across reporting periods, while the comparison chart places KKPCF next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.